Par Pharmaceutical Companies
Par Pharmaceutical Companies: quarterly report for the quarter ended Mar 28, 2009
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0000878088-09-000036
- Document
- 10-Q
- Exhibit 10.1
- Separation agreement and release
- Exhibit 10.2
- Asset purchase agreement
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2834) and public float not reported.
